Graybug Vision’s Technology

Graybug is developing injectable drug-eluting microparticle products for both posterior segment (back of eye) and anterior segment (front of eye) ophthalmic diseases. The unique microparticle platform is tunable to allow variable drug-elution profiles without burst effects, providing the potential to deliver therapeutic drug doses over several weeks to several months.